Our plasma proteomics analyses identified several key features associated with AD progression, including significant downregulation of SKAP1, VPS37A, CALCOCO1, and SF3B4, and significant upregulation of NEFL and GFAP. The gene discussed is VPS37A; the disease is Alzheimer disease.